Company Search:
Advanced Search
Sponsored Links
Transgene Company Snapshot
Transgene operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Transgene with three other pharmaceutical manufacturers in Europe: Byotrol PLC of the United Kingdom (2017 sales of £3.13 million [US$4.22 million] of which 38% was Professional), Erytech Pharma SA (3.36 million Euro [US$3.97 million] of which 100% was Pharmacy), and Co Don AG which is based in Germany (5.96 million Euro [US$7.04 million] ).

Sales Analysis. During the year ended December of 2017, sales at Transgene were 7.46 million Euro (US$8.80 million). This is a decrease of 14.6% versus 2016, when the company's sales were 8.73 million Euro. Contributing to the drop in overall sales was the 97.7% decline in Research and Development Subsidies, from 129,000.00 Euro to 3,000.00 Euro. There were also decreases in sales in Research and Development Tax Credit (down 14.4% to 5.36 million Euro) and Royalties and Licenses (down 33.1% to 1.20 million Euro) . However, these declines were partially offset by the increase in sales of Bio-Production and Cooperations (up 63.5% to 896,000.00 Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Transgene
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 2.97
(Figures in Euro)
1 Week 4.8%   13 Weeks -1.8%  
4 Weeks -5.1%   52 Weeks -11.0%  
Transgene Key Data:
  Ticker: TNG Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 7,457,000
(Year Ending Jan 2018).
Employees: 146
  Currency: Euro Market Cap: 184,052,938
  Fiscal Yr Ends: December Shares Outstanding: 62,075,190
  Share Type: Actions Ordinaires Closely Held Shares: 38,380,133
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.